Oasmia Pharmaceutical AB Issue Of Equity
Oasmia Pharmaceutical AB reported Issue Of Equity of SEK 163.50 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Notes
ifrs-full:IssueOfEquity · last filed 2018-09-14
| Period end | Issue Of Equity 12 month |
|---|---|
| 2018-04-30 | 163.50M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | 137.00M SEK 20-F · filed 2018-09-14 |